Natera files patent lawsuit against Progenity

By staff writers

June 19, 2020 -- Natera has filed a lawsuit against Progenity for infringing six U.S. patents.

The suit was filed in the U.S. District Court for the Western District of Texas and alleges the use and sale of Progenity's noninvasive prenatal test infringes upon six of Natera's patents. The firm is seeking injunctive relief as well as monetary damages, according to a press statement.

New technique improves Natera's organ transplant test
Natera has launched a new technique that enhances results from Prospera, the company's donor-derived cell-free DNA organ transplant laboratory-developed...
Natera's prenatal testing coverage expands
A national insurer has expanded coverage of Natera's Panorama cell-free DNA and noninvasive prenatal test to all pregnant women, regardless of age. Natera...
Natera releases pricing for Prospera cell-free DNA test
Cell-free DNA testing company Natera has released pricing for its Prospera donor-derived cell-free DNA organ transplant laboratory-developed test.
Natera evaluates serial cfDNA blood testing in colon cancer
Cell-free DNA (cfDNA) testing company Natera is launching a study this year of its Signatera blood test in patients with stage II/III colorectal cancer...
Foundation, Natera join to develop ctDNA assays
Foundation Medicine and Natera are joining forces to develop and commercialize personalized circulating tumor DNA (ctDNA) monitoring assays.

Copyright © 2020

Last Updated ls 6/19/2020 2:49:05 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.